REVIEW ARTICLE, Immunological Factors in the Pathogenesis and Treatment of Age-Related Macular Degeneration

REFERENCES

• Klein R, Wang Q, Klein B EK, Moss S E, Meuer S E. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Visual Sci 1995; 36(1)182–191, [CSA]
   PubMed Web of Science ®Google Scholar
• Penfold P L, Provis J M, Furby J H, Gatenby P A, Billson F A. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefe's Arch Clin Exp Ophthalmol 1990; 228(3)270–274, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gurne D H, Tso M OM, Edward D P, Ripps H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 1991; 98(5)602–607, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Doekes G, Van Der Gaag R, Rothova A, Van Kooyk Y, Broersma L, Zaal M J, Dijkman G, Fortuin M E, Baarsma G S, Kijlstra A. Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res 1987; 6: 909–919, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• De Smet M D, Chan C C. Regulation of ocular inflammation—what experimental and human studies have taught us. Prog Retin Eye Res 2001; 20: 761–797, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Penfold P L, Madigan M C, Gillies M C, et al. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001; 20: 385–414, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Higgins G T, Wang J H, Dockery P, et al. Induction of angiogenic cytokine expression in cultured RPE by ingestion of oxidized photoreceptor outer segments. Invest Ophthalmol Visual Sci 2003; 44: 1775–1782, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Hageman G S, Luthert P J, Chong N HV, Johnson L V, Anderson D H, Mullins R F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20(6)705–732, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Blaauwgeers H GT, Holtkamp G M, Rutten H, Witmer A N, Koolwijk P, Partanen T A, Alitalo K, Kroon M E, Kijlstra A, Van Hinsbergh V WM, Schlingemann R O. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 1999; 155(2)421–428, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Holtkamp G M, Van Rossem M, De Vos A F, Willekens B, Peek R, Kijlstra A. Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol 1998; 112(1)34–43, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Holtkamp G M, De Vos A F, Peek R, Kijlstra A. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta 2) by human retinal pigment epithelial cells. Clin Exp Immunol 1999; 118(1)35–40, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Radisavljevic Z, Avraham H, Avraham S. Vascular endothelial growth factor up-regulates ICAM-1 expression via the phosphatidylinositol 3 OH-kinase/AKT/nitric oxide pathway and modulates migration of brain microvascular endothelial cells. J Biol Chem 2000; 275(27)20770–20774, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Espinosa-Heidmann D G, Suner I J, Hernandez E P, Monroy D, Csaky K G, Cousins S W. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Visual Sci 2003; 44(8)3586–3592, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sakurai E, Anand A, Ambati B K, Van Rooijen N, Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Visual Sci 2003; 44(8)3578–3585, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Anderson D H, Mullins R F, Hageman G S, Johnson L V. Perspective—A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134(3)411–431, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Nauta A J, Daha M R, Van Kooten C, et al. Recognition and clearance of apoptotic cells: a role for complement and pentraxins. Trends Immunol 2003; 24(3)148–154, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Van der Schaft T L, Mooy C M, Debruijn W C, Dejong P TVM. Early stages of age-related macular degeneration—an immunofluorescence and electron-microscopy study. Br J Ophthalmol 1993; 77(10)657–661, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Johnson L V, Leitner W P, Staples M K, Anderson D H. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 2001; 73(6)887–896, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Newsome D A, Hewitt A T, Huh W, Robey P G, Hassell J R. Detection of specific extracellular matrix molecules in drusen, Bruch's membrane, and ciliary body. Am J Ophthalmol 1987; 104: 373–381, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Johnson L V, Ozaki S, Staples M K, Erickson P A, Anderson D H. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000; 70(4)441–449, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• McLaughlin B J, Fan W, Zheng J J, et al. Novel role for a complement regulatory protein (CD46) in retinal pigment epithelial adhesion. Invest Ophthalmol Visual Sci 2003; 44(8)3669–3674, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Fukuoka Y, Strainic M, Medof M E. Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a. Clin Exp Immunol 2003; 131: 248–253, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mullins R F, Russell S R, Anderson D H, Hageman G S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14: 835–846, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Johnson L V, Leitner W P, Rivest A J, Staples M K, Radeke M J, Anderson D H. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 2002; 99(18)11830–11835, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Dentchev T, Milam A H, Lee V MY, et al. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol Vis 2003; 9: 184–190, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Van Beek J, Elward K, Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann NY Acad Sci 2003; 992: 56–71, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Forrester J V, McMenamin P G, Holthouse I, Lumsden L, Liversidge J. Localization and characterization of major histocompatibility complex class II-positive cells in the posterior segment of the eye—implications for induction of autoimmune uveoretinitis. Invest Ophthalmol Visual Sci 1994; 35: 64–77, [CSA]
   PubMed Web of Science ®Google Scholar
• Chen L, Zwart R, Yang P Z, Kijlstra A. Macrophages and MHC class II positive dendritiform cells in the iris and choroid of the pig. Curr Eye Res 2003; 26: 291–296, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wang J J, Mitchell P, Smith W, et al. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmic Epidemiol 2003; 10: 37–48, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wang Y S, Friedrichs U, Eichler W, Hoffmann S, Wiedemann P. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefe's Arch Clin Exp Ophthalmol 2002; 240: 42–48, [CSA]
   PubMed Web of Science ®Google Scholar
• Ciulla T A, Criswell M H, Danis R P, Hill T E. Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 2001; 119: 399–404, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Ranson N T, Danis R P, Ciulla T A, Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol 2002; 86: 527–529, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Gillies M C, Simpson J M, Luo W, Penfold P, Hunyor A BL, Chua W, Mitchell P, Billson F. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one year results. Arch Ophthalmol 2003; 121: 667–673, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jonas J B, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003; 87: 462–468, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Spaide R F, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 110: 1517–1525, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Jonas J B, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24–27, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Sutter F KP, Gillies M C. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003; 87(8)972–974, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Penn J S, Rajaratnam V S, Collier R J, Clark A F. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest OphthalmolVisual Sci 2001; 42(1)283–290, [CSA]
   PubMedGoogle Scholar
• Blinder K, Blumenkranz M, De Smet M, Fish G, Friedlander M, Gitter K, Godley B, Ho A, Hudson H, Van Kuijk E, Lewis M L, Rosenfeld P, Russell S, Sabates F, Schachat A, Schmidt-Erfurth U, Schwartz S, Singerman L, Soubrane G, Yannuzzi L, D'Amico D J, Regillo C, Mieler W F, Schneebaum C, Beasley C, Slakter J S, Ciardella A, Goldberg M F, Hudson H, Jerdan J A, Krueger S, Luna S, Robertson S M, Russell S, Singerman L, Slakter J S, Sullivan E K, Yannuzzi L, Zilliox P. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD)—interim (month 6) analysis of clinical safety and efficacy. Retina J Retin Vitreous Dis 2003; 23: 14–23, [CSA]
   PubMedGoogle Scholar
• Miller D M, Legra J M, Dubovy S R, Suner I J, Dix R D, Sedmak D D, Cousins S W The association of exudative age-related macular degeneration with prior infection. Invest Ophthalmol Visual Sci 2003; 45, ARVO E-abstract 1747
   Google Scholar
• Kalayoglu M V, Galvan C, Mahdi O S, Byrne G I, Mansour S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 2003; 121: 478–482, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ishida O, Oku H, Ikeda T, Nishimura M, Kawagoe K, Nakamura K. Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?. Br J Ophthalmol 2003; 87: 523–524, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Kalayoglu M V, Bula D, Arroyo J, Gragoudas E S, Miller J W. Detection of Chlamydia pneumoniae in choroidal neovascular membranes isolated from patients with age-related macular degeneration. Invest Ophthalmol Visual Sci. 2003; 45, ARVO E-abstract 5023
   Google Scholar
• Blumenkranz M S, Bressler N M, Bressler S B, Donati G, Fish G E, Haynes L A, Lewis H, Miller J W, Mones J M, Potter M J, Pournaras C, Reaves A, Rosenfeld P J, Schachat A P, Schmidt-Erfurth U, Sickenburg M, Singerman L J, Slakter J S, Strong A, Vannier S. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials. TAP Report No. 5. Arch Ophthalmol. 2002; 120: 1307–1314, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Bora P S, Hu Z W, Tezel T H, Sohn J H, Kang S G, Cruz J MC, Bora N S, Garen A, Kaplan H J. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc Natl Acad Sci USA 2003; 100: 2679–2684, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber H P, Le Couter J. The biology of VEGF and its receptors. Nat Med 2003; 9: 669–676, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Kliffen M, Sharma H S, Mooy C M, et al. Increased expression of angiogenic growth factors in age-related maculopathy. Br J Ophthalmol. 1997; 81: 154–162, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kvanta A, Algvere P V, Berglin L, et al. Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Visual Sci. 1996; 37: 1929–1934, [CSA]
   PubMed Web of Science ®Google Scholar
• Krzystolik M G, Afshari M A, Adamis A P, Gaudreault J, Gragoudas E S, Michaud N A, Li W J, Connolly E, O'Neill C A, Miller J W. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 2002; 120: 338–346, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Martin D F, Klein M, Haller J, et al. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina J Retin Vitreous Dis. 2002; 22: 143–152, [CSA]
   PubMedGoogle Scholar
• Fish G, Haller J A, Ho A C, Klein M, Loewenstein J, Martin D, Orth D, Rosen R B, Sanislo S, Schwartz S D, Singerman L J, Williams G, Adamis A P, Blumenkranz M, Goldberg M, Gragoudas E S, Miller J W, Yannuzzi L, Guyer D R, O'Shaughnessy D, Patel S. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration—phase II study results. Ophthalmology 2003; 110: 979–986, [CSA]
   PubMedGoogle Scholar
• Rosenfeld P J, Villate N, Feuer W J, Puliafito C A, McCluskey E R. RhuFab V2 (anti-VEGF antibody fragment) in neovascular AMD: safety, tolerability, and efficacy of multiple, escalating dose intravitreal injections. Invest Ophthalmol Visual Sci. 2003; 45, ARVO E-abstract 970
   Google Scholar
• Ohno-Matsui K, Morita I, Tombran-Tink J, Mrazek D, Onodera M, Uetama T, Hayano M, Murota S I, Mochizuki M. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J Cell Physiol 2001; 189: 323–333, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mori K, Gehlbach P, Yamamoto S, Dub E, Zack D J, Li Q H, Berns K I, Raisler B J, Hauswirth W W, Campochiaro P A. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest OphthalmolVisual Sci. 2002; 43: 1994–2000
   PubMed Web of Science ®Google Scholar
• Otani A, Takagi H, Oh H, Koyama S, Matsumura M, Honda Y. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes. Invest Ophthalmol Visual Sci 1999; 40: 1912–1920, [CSA]
   PubMed Web of Science ®Google Scholar
• Binder S, Stolba U, Krebs I, Kellner L, Jahn C, Feichtinger H, Povelka M, Frohner U, Kruger A, Hilgers R D, Krugluger W. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol. 2002; 133: 215–225, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Phillips S J, Sadda S R, Tso M OM, Humayan M S, de Juan E, Binder S. Autologous transplantation of retinal pigment epithelium after mechanical debridement of Bruch's membrane. Curr Eye Res 2003; 26: 81–88, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Holz F G, Bindewald A, Schutt F, Specht H. Intraocular microablation of choroidal tissue by a 308 nm AIDA excimer laser for RPE-transplantation in patients with age-related macular degeneration. Biomed Tech 2003; 48: 82–85, [CSA]
   PubMedGoogle Scholar
• Van Meurs J C, Van Den Biesen P R. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol 2003; 136: 688–695, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Humayun M S, de Juan E, del Cerro M, Dagnelie G, Radner W, Sadda S R, del Cerro C. Human neural retinal transplantation. Invest Ophthalmol Visual Sci 2000; 41: 3100–3106, [CSA]
   PubMed Web of Science ®Google Scholar
• Berger A S, Tezel T H, Del Priore L V, Kaplan H J. Photoreceptor transplantation in retinitis pigmentosa—short-term follow-up. Ophthalmology 2003; 110: 383–391, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Del Cerro M, Humayun M S, Sadda S R, Cao J T, Hayashi N, Green W R, del Cerro C, de Juan E. Histologic correlation of human neural retinal transplantation. Invest Ophthalmol Visual Sci 2000; 41: 3142–3148, [CSA]
   PubMedGoogle Scholar
• Lappas A, Weinberger W A, Foerster A MH, Kube T, Rezai K A, Kirchhof B. Iris pigment epithelial cell translocation in exudative age-related macular degeneration—a pilot study in patients. Graefe's Arch Clin Exp Ophthalmol 2000; 238: 631–641, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Semkova I, Kreppel F, Welsandt G, Luther T, Kozlowski J, Janicki H, Kochanek S, Schraermeyer U. Autologous transplantation of genetically modified iris pigment epithelial cells: a promising concept for the treatment of age-related macular degeneration and other disorders of the eye. Proc Natl Acad Sci USA 2002; 99: 13090–13095, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Abdel-Meguid A, Lappas A, Hartmann K, Auer F, Schrage N, Thumann G, Kirchhof B. One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration. Br J Ophthalmol 2003; 87: 615–621, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fujii G Y, de Juan E, Jr, Pieramici D J, Humayun M S, Phillips S, Reynolds S M, Melia M, Schachat A P. Inferior limited macular translocation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: 1-year visual outcome and recurrence report. Am J Ophthalmol 2002; 134: 69–74, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Ohji M, Fujikado T, Kusaka S, Hayashi A, Hosohata J, Ikuno Y, Sawa M, Kubota A, Hashida N, Tano Y. Comparison of three techniques of foveal translocation in patients with subfoveal choroidal neovascularization resulting from age-related macular degeneration. Am J Ophthalmol 2001; 132: 888–896, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Streilein J W, Ma N L, Wenkel H, Ng T F, Zamiri P. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res 2002; 42: 487–495, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wenkel H, Streilein J W. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest Ophthalmol Visual Sci 1998; 39: 1823–1834, [CSA]
   PubMed Web of Science ®Google Scholar
• Wenkel H, Streilein J W. Evidence that retinal pigment epithelium functions as an immune-privileged tissue. Invest Ophthalmol Visual Sci 2000; 41: 3467–3473, [CSA]
   PubMedGoogle Scholar
• Ng T F, Osawa H, Hori J, et al. Allogeneic neonatal neuronal retina grafts display partial immune privilege in the subcapsular space of the kidney. J Immunol 2002; 169: 5601–5606, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Ma N, Streilein J W. Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts. Invest Ophthalmol Visual Sci 1998; 39: 2384–2393, [CSA]
   PubMedGoogle Scholar
• Gouras P, Tanabe T. Survival and integration of neural retinal transplants in rd mice. Graefe's Arch Clin Exp Ophthalmol 2003; 241: 403–409, [CSA]
   PubMedGoogle Scholar
• Kohen L, Enzmann V, Faude F, Widermann P. Mechanisms of graft rejection in the transplantation of retinal pigment epithelial cells. Ophthalmic Res 1997; 29: 298–304, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Zhang X, Bok D. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Visual Sci. 1998; 39: 1021–1027, [CSA]
   PubMed Web of Science ®Google Scholar